Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6775-6780

  Weck, Karen E ^a   Barkon, Melissa L ^a   Yoo, Lina I ^a   Speck, Samuel H ^a   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; HERPES VIRUS; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029817996     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6775-6780.1996     Document Type: Article

References (33)

1. Battegay, M., D. Moskophidis, H. Waldner, M.-A. Brundler, W. P. Fung-Leung, T. W. Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotosic T cells. J. Immunol. 151:5408-5415.
2. Blaskovic, D., D. Stanekova, and J. Rajcani. 1984. Experimental pathogenesis of murine herpesvirus in newborn mice. Acta Virol. 28:225-231.
3. Blaskovic, D., M. Stancekova, J. Svobodova, and J. Mistrikova. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24:468.
4. Cook, J. R., J. C. Solheim, J. M. Connoly, and T. H. Hansen. 1995. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice. J. Immunol. 154:47-57.
5. Doherty, P. C., S. Hou, and P. J. Southern. 1993. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J. Neuroimmunol. 46:11-18.
6. Efstathiou, S., Y. M. Ho, and A. C. Minson. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J. Gen. Virol. 71: 1355-1364.
7. Efstathiou, S., Y. M. Ho, S. Hall, C. J. Styles, S. D. Scott, and U. A. Gompels. 1990. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71:1365-1372.
8. Ehtisham, S., N. P. Sunil-Chandra, and A. A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247-5252.
9. Fiette, L., C. Aubert, M. Brahic, and C. Pena Rossi. 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589-592.
10. Gratama, J. W., E. T. Lennette, B. Lonnqvist, M. A. Oosterveer, G. Klein, O. Ringden, and I. Ernberg. 1992. Detection of multiple Epstein-Barr virol strains in allogeneic bone marrow transplant recipients. J. Med. Virol. 37: 39-47.
11. Gratama, J. W., M. A. Oosterveer, J. Lepoutre, J. J. van Rood, F. E. Zwaan, J. M. Vossen, J. G. Kapsenberg, G. Klein, and I. Ernberg. 1989. Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. Transplant. Proc. 21:3097-3098.
12. Gratama, J. W., M. A. Oosterveer, J. M. Lepoutre, J. J. van Rood, F. E. Zwaan, J. M. Vossen, J. G. Kapsenberg, D. Richel, G. Klein, and I. Ernberg. 1990. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation 49:725-730. (Erratum, 50:910.)
13. Gratama, J. W., M. A. Oosterveer, F. E. Zwaan, J. Lepoutre, G. Klein, and I. Ernberg. 1988. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl. Acad. Sci. USA 85:8693-8696.
14. Gratama, J. W., M. M. Zutter, J. Minarovits, M. A. Oosterveer, E. D. Thomas, G. Klein, and I. Ernberg. 1991. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of hone marrow transplant recipients. Int. J. Cancer 47:188-192.
15. Hou, S., P. C. Doherty, M. Zijlstra, R. Jaenisch, and J. M. Katz. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
16. + T cells from mice with Sendai virus pneumonia. J. Virol. 67:6299-6302.
17. Hyland, L., S. Hou, C. Coleclough, T. Takimoto, and P. C. Doherty. 1994. Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection. Virology 204:234-241.
18. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (London) 350:423-426.
19. Koller, B. H., P. Marrack, J. W. Kappler, and O. Smithies. 1990. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248:1227-1230.
20. Lehmann-Grube, F., H. Dralle, O. Utermahlen, and J. Lohler. 1994. MHC class I molecule-restricted presentation of viral antigen in beta2-microglobulin-deficient mice. J. Immunol. 153:595-603.
21. + T lymphocytes because of disruption of the β2-microglobulin gene. J. Virol. 67:332-339.
22. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-I. Nature (London) 375:685-688.
23. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
24. Mistrikova, J., and D. Blaskovic. 1985. Ecology of the murine alphaherpes-virus and its isolation from lungs of rodents in cell culture. Acta Virol. 29:312-317.
25. Muller, D., B. H. Koller, J. L. Whitton, K. E. LaPan, K. K. Brigman, and J. A. Frelinger. 1992. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science 255:1576-1578.
26. Pollock, J. L., and H. W. Virgin. 1995. Latency without persistence of murine cytomegalovirus in spleen and kidney. J. Virol. 69:1762-1768.
27. Rajcani, J., D. Blaskovic, J. Svobodova, F. Ciampor, D. Huckova, and D. Stanekova. 1985. Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol. 29:51-60.
28. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Virology. Lippincott-Raven, Philadelphia.
29. Rodriguez, M., A. J. Dunkel, R. L. Thiemann, J. Leibowitz, M. Zijlstra, and R. Jaenisch. 1993. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta2-microglobulin. J. Immunol. 151:266-276.
30. Stewart, J. P., N. J. Janjua, N. P. Sunil-Chandra, A. A. Nash, and J. R. Arrand. 1994. Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gpl 10). J. Virol. 68:6496-6504.
31. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gammaherpesvirus 68. J. Gen. Virol. 73:2347-2356.
32. Sunil-Chandra, N. P., S. Efstathiou, and A. A. Nash. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275-3279.
33. Wallace, L. E., and R. J. Murray. 1989. Immunological aspects of the Epstein-Barr virus system, p. 219-236. In G. Klein (ed.), Tumorigenic DNA viruses. Raven Press, New York.